Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment.
Department of Medicine, Queen Mary Hospital, Hong Kong.
Wing-Yan
WY
Au
Sidney
S
Tam
Yok-Lam
YL
Kwong
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001151:Arsenic / Q000134:cerebrospinal fluid*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D002490:Central Nervous System / Q000737:chemistry*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D001151:Arsenic; D000077237:Arsenic Trioxide